Neuroendocrine Tumor — Trials

Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 301–336 of 336 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01048892	Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features	completed	Phase 1	22	Children's Oncology GroupNETWORK	1	Jan 30, 2014	clinicaltrials
NCT00031681	7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	completed	Phase 1	41	National Cancer Institute (NCI)NIH